Detalhe da pesquisa
1.
VIRMA promotes nasopharyngeal carcinoma, tumorigenesis, and metastasis by upregulation of E2F7 in an m6A-dependent manner.
J Biol Chem
; 299(5): 104677, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37028765
2.
Prognostic value of pre-treatment [18F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis.
BMC Cancer
; 24(1): 466, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38622555
3.
Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial.
Lancet Oncol
; 23(4): 479-490, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35240053
4.
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.
Lancet
; 398(10297): 303-313, 2021 07 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34111416
5.
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.
N Engl J Med
; 381(12): 1124-1135, 2019 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31150573
6.
Association of delayed chemoradiotherapy with elevated Epstein-Barr virus DNA load and adverse clinical outcome in nasopharyngeal carcinoma treatment during the COVID-19 pandemic: a retrospective study.
Cancer Cell Int
; 22(1): 331, 2022 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316696
7.
Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
BMC Cancer
; 22(1): 714, 2022 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35768785
8.
Causal relationship between genetically predicted depression and cancer risk: a two-sample bi-directional mendelian randomization.
BMC Cancer
; 22(1): 353, 2022 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35361153
9.
Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial.
JAMA
; 328(8): 728-736, 2022 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35997729
10.
Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses.
Mol Cancer
; 20(1): 14, 2021 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33430876
11.
Evolving landscape and academic attitudes toward the controversies of global immuno-oncology trials.
Int J Cancer
; 149(1): 108-118, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33544890
12.
FNDC3B 3'-UTR shortening escapes from microRNA-mediated gene repression and promotes nasopharyngeal carcinoma progression.
Cancer Sci
; 111(6): 1991-2003, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32232887
13.
Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
Eur Radiol
; 30(2): 816-822, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31650266
14.
Spontaneous remission of residual post-therapy plasma Epstein-Barr virus DNA and its prognostic implication in nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis.
Int J Cancer
; 144(9): 2313-2319, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30485420
15.
Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial.
Int J Cancer
; 145(1): 295-305, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30613964
16.
Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
Cancer
; 125(1): 79-89, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30351466
17.
Evidence Underlying Recommendations and Payments from Industry to Authors of the National Comprehensive Cancer Network Guidelines.
Oncologist
; 24(4): 498-504, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30459237
18.
Deep Learning for Automated Contouring of Primary Tumor Volumes by MRI for Nasopharyngeal Carcinoma.
Radiology
; 291(3): 677-686, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30912722
19.
Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959).
BMC Med
; 17(1): 190, 2019 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31640711
20.
Correction: Prognostic value of pre-treatment [18F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis.
BMC Cancer
; 24(1): 528, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38664684